Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Adaptimmune
University of Pittsburgh
UNC Lineberger Comprehensive Cancer Center
MacroGenics
Virginia Commonwealth University
Mayo Clinic
Incyte Corporation
Palleon Pharmaceuticals, Inc.
Incyte Corporation
MacroGenics
Memorial Sloan Kettering Cancer Center
Genentech, Inc.
Shanghai Junshi Bioscience Co., Ltd.
NGM Biopharmaceuticals, Inc
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Revolution Medicines, Inc.
Labcorp Corporation of America Holdings, Inc
Stanford University
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Children's National Research Institute
Eli Lilly and Company
AstraZeneca
RECORDATI GROUP
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
GlaxoSmithKline
AstraZeneca
Mayo Clinic
Xencor, Inc.
Centre hospitalier de l'Université de Montréal (CHUM)
National Institutes of Health Clinical Center (CC)
University of Southern California
Cedars-Sinai Medical Center
Exelixis
Eli Lilly and Company
Celldex Therapeutics
University of California, San Francisco
NextCure, Inc.
Albert Einstein College of Medicine
National Cancer Institute (NCI)
Apexigen America, Inc.
Deciphera Pharmaceuticals, LLC
Rutgers, The State University of New Jersey
M.D. Anderson Cancer Center
Sumitomo Pharma America, Inc.
HUYABIO International, LLC.
University of Nebraska